IMDX

MKT CAP:$199M

Insight Molecular Diagnostics Inc.

Market Cap

$199M

Healthcare·Diagnostics & Research·🇺🇸 United States·NASDAQ

Healthcare·Diagnostics·🇺🇸·NASDAQ

Stock Price

$5.24-$1.92 (-26.82%)

Jun 5, 2026

52W High $8.4852W Low $2.40

Company Details

Insight Molecular Diagnostics Inc. operates as a precision diagnostics company in the United States and internationally. The company develops and commercializes laboratory developed tests, kitted research use only tests, and kitted clinical...

CEO

—

IPO Date

Jan 4, 2016

Website

www.imdxinc.com

Key Metrics TTM

Revenue

$2M

-49.3% YoY

Net Income

-$48M

EPS (Diluted)

Free Cash Flow

-$27M

Revenue / Share

$0.06

Gross Margin

19.5%

Operating Margin

-2112.4%

Net Margin

-2454.6%

FCF Margin

-1408.7%

P/S

102.1x

P/E

Earnings Reports

Q1 2026

May 13, 2026

$32.0K-98.5%

FY 2025

Mar 26, 2026

$4M+115.6%

Q4 2025

Mar 26, 2026

$1M-23.4%

Q3 2025

Nov 10, 2025

$260.0K+126.1%

Q2 2025

Aug 11, 2025

$518.0K+398.1%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee